These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10530810)

  • 1. Inhibition of N-linked glycosylation of the human type 1alpha metabotropic glutamate receptor by tunicamycin: effects on cell-surface receptor expression and function.
    Mody N; Hermans E; Nahorski SR; Challiss RA
    Neuropharmacology; 1999 Oct; 38(10):1485-92. PubMed ID: 10530810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of varying the expression level of recombinant human mGlu1alpha receptors on the pharmacological properties of agonists and antagonists.
    Hermans E; Challiss RA; Nahorski SR
    Br J Pharmacol; 1999 Feb; 126(4):873-82. PubMed ID: 10193767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell type-specific differences in the coupling of recombinant mGlu1alpha receptors to endogenous G protein sub-populations.
    Selkirk JV; Price GW; Nahorski SR; Challiss RA
    Neuropharmacology; 2001 Apr; 40(5):645-56. PubMed ID: 11311892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible and non-competitive antagonist profile of CPCCOEt at the human type 1alpha metabotropic glutamate receptor.
    Hermans E; Nahorski SR; Challiss RA
    Neuropharmacology; 1998 Dec; 37(12):1645-7. PubMed ID: 9886688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complex involvement of pertussis toxin-sensitive G proteins in the regulation of type 1alpha metabotropic glutamate receptor signaling in baby hamster kidney cells.
    Hermans E; Saunders R; Selkirk JV; Mistry R; Nahorski SR; Challiss RA
    Mol Pharmacol; 2000 Aug; 58(2):352-60. PubMed ID: 10908303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modulatory effect of extracellular Ca2+ on type 1alpha metabotropic glutamate receptor-mediated signalling.
    Saunders R; Nahorski SR; Challiss RA
    Neuropharmacology; 1998; 37(2):273-6. PubMed ID: 9680253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homer-1c/Vesl-1L modulates the cell surface targeting of metabotropic glutamate receptor type 1alpha: evidence for an anchoring function.
    Ciruela F; Soloviev MM; Chan WY; McIlhinney RA
    Mol Cell Neurosci; 2000 Jan; 15(1):36-50. PubMed ID: 10662504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced inducible mGlu1alpha receptor expression in Chinese hamster ovary cells.
    Nash MS; Selkirk JV; Gaymer CE; Challiss RA; Nahorski SR
    J Neurochem; 2001 Jun; 77(6):1664-7. PubMed ID: 11413250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of an N-terminal secreted domain of the type-1 human metabotropic glutamate receptor produced by a mammalian cell line.
    Selkirk JV; Challiss RA; Rhodes A; McIlhinney RA
    J Neurochem; 2002 Jan; 80(2):346-53. PubMed ID: 11905408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human type 1alpha metabotropic glutamate receptor expression level on phosphoinositide and Ca2+ signalling in an inducible cell expression system.
    Hermans E; Young KW; Challiss RA; Nahorski SR
    J Neurochem; 1998 Apr; 70(4):1772-5. PubMed ID: 9523598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression.
    Remaley AT; Ugorski M; Wu N; Litzky L; Burger SR; Moore JS; Fukuda M; Spitalnik SL
    J Biol Chem; 1991 Dec; 266(35):24176-83. PubMed ID: 1748686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced type 1alpha metabotropic glutamate receptor-stimulated phosphoinositide signaling after pertussis toxin treatment.
    Carruthers AM; Challiss RA; Mistry R; Saunders R; Thomsen C; Nahorski SR
    Mol Pharmacol; 1997 Sep; 52(3):406-14. PubMed ID: 9281602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co- and posttranslational modification of the alpha(1B)-adrenergic receptor: effects on receptor expression and function.
    Björklöf K; Lundström K; Abuin L; Greasley PJ; Cotecchia S
    Biochemistry; 2002 Apr; 41(13):4281-91. PubMed ID: 11914074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist.
    Gasparini F; Lingenhöhl K; Stoehr N; Flor PJ; Heinrich M; Vranesic I; Biollaz M; Allgeier H; Heckendorn R; Urwyler S; Varney MA; Johnson EC; Hess SD; Rao SP; Sacaan AI; Santori EM; Veliçelebi G; Kuhn R
    Neuropharmacology; 1999 Oct; 38(10):1493-503. PubMed ID: 10530811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group-I metabotropic glutamate receptors, mGlu1a and mGlu5a, couple to extracellular signal-regulated kinase (ERK) activation via distinct, but overlapping, signalling pathways.
    Thandi S; Blank JL; Challiss RA
    J Neurochem; 2002 Dec; 83(5):1139-53. PubMed ID: 12437585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional regulation of metabotropic glutamate receptor type 1c: a role for phosphorylation in the desensitization of the receptor.
    Ciruela F; Giacometti A; McIlhinney RA
    FEBS Lett; 1999 Dec; 462(3):278-82. PubMed ID: 10622711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
    Li JG; Chen C; Liu-Chen LY
    Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astroglial phosphoinositide hydrolysis during combined glucose-oxygen deprivation: role of the metabotropic glutamate receptor.
    Segeleon JE; Lipscomb DC; Haun SE; Trapp VL; Horrocks LA
    J Neurochem; 1995 Sep; 65(3):1115-23. PubMed ID: 7643089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel metabotropic glutamate receptor agonist 2R,4R-APDC potentiates stimulation of phosphoinositide hydrolysis in the rat hippocampus by 3,5-dihydroxyphenylglycine: evidence for a synergistic interaction between group 1 and group 2 receptors.
    Schoepp DD; Salhoff CR; Wright RA; Johnson BG; Burnett JP; Mayne NG; Belagaje R; Wu S; Monn JA
    Neuropharmacology; 1996; 35(12):1661-72. PubMed ID: 9076745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.